L. J. Kay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
L. J. Kay has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
D. A. Coady
1 shared publicationD. Coady
Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
1 shared publicationD. Walker
Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
1 shared publicationG. Baggott
1 shared publicationH. E. Foster
1 shared publicationI. D. Griffiths
Musculoskeletal Unit, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN and Musculoskeletal Research Group, University of Newcastle NE2 1HH, UK
1 shared publication
Latest Publications
- Open Access
- 10 October 2006
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (11) , 1376-1379
UK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register
Objectives. The British Society for Rheumatology Biologics Register (BSRBR) is a prospective cohort study to determine the efficacy and toxicity of biological agents in rheumatoid arthritis (RA) patients compared with RA controls. Entry of patients to the register is a condition of use of anti-tumour necrosis factor (anti-TNF) therapy in the UK, but little is known of clinicians’ views of its usefulness. Data from the register suggest uneven provision of anti-TNF-α therapy. Methods. A questionnaire was sent on behalf of the BSRBR to all UK consultant rheumatologists concerning provision and use of anti-TNF-α therapy and their experience of working with the BSRBR. Results. Response rate was 49.5% representing 252 consultants. Fourty-six per cent had some limitation of access to anti-TNF-α drugs, usually a financial cap (70%), even for RA patients meeting National Institute for Health and Clinical Excellence (NICE) criteria. Sixty-seven per cent could prescribe for ankylosing spondylitis (AS) or psoriatic arthritis (PsA) in some circumstances but only 25 and 35%, respectively, could prescribe according to BSR guidance. More than 50% found the workload involved in submitting data to the registry at least difficult, but most had favourable impressions of the BSRBR and thought similar registries desirable or essential for PsA, AS and rituximab. Conclusions. Access to anti-TNF therapy for patients with inflammatory arthritis is variable in the UK, even for RA where it is NICE-approved. Access is more limited for conditions where NICE has not yet issued guidance. The BSRBR generates a significant workload for rheumatology staff but is generally well-regarded.
- 10 October 2006
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (11) , 1376-1379
Open AccessUK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register
Objectives. The British Society for Rheumatology Biologics Register (BSRBR) is a prospective cohort study to determine the efficacy and toxicity of biological agents in rheumatoid arthritis (RA) patients compared with RA controls. Entry of patients to the register is a condition of use of anti-tumour necrosis factor (anti-TNF) therapy in the UK, but little is known of clinicians’ views of its usefulness. Data from the register suggest uneven provision of anti-TNF-α therapy. Methods. A questionnaire was sent on behalf of the BSRBR to all UK consultant rheumatologists concerning provision and use of anti-TNF-α therapy and their experience of working with the BSRBR. Results. Response rate was 49.5% representing 252 consultants. Fourty-six per cent had some limitation of access to anti-TNF-α drugs, usually a financial cap (70%), even for RA patients meeting National Institute for Health and Clinical Excellence (NICE) criteria. Sixty-seven per cent could prescribe for ankylosing spondylitis (AS) or psoriatic arthritis (PsA) in some circumstances but only 25 and 35%, respectively, could prescribe according to BSR guidance. More than 50% found the workload involved in submitting data to the registry at least difficult, but most had favourable impressions of the BSRBR and thought similar registries desirable or essential for PsA, AS and rituximab. Conclusions. Access to anti-TNF therapy for patients with inflammatory arthritis is variable in the UK, even for RA where it is NICE-approved. Access is more limited for conditions where NICE has not yet issued guidance. The BSRBR generates a significant workload for rheumatology staff but is generally well-regarded.
- Open Access
- 1 June 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (8) , 1062
Joint examination skills: are rheumatology specialist registrars adequately trained? Reply
Mistlin's survey is a timely reminder that the well-known problem of poor confidence in musculoskeletal examination skills is not confined to medical students [1], general practitioners [2, 3] or general physicians [4], but is present also in rheumatology specialist registrars. This problem has been generally overlooked and has a number of possible causes.
- 1 June 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (8) , 1062
Open AccessJoint examination skills: are rheumatology specialist registrars adequately trained? Reply
Mistlin's survey is a timely reminder that the well-known problem of poor confidence in musculoskeletal examination skills is not confined to medical students [1], general practitioners [2, 3] or general physicians [4], but is present also in rheumatology specialist registrars. This problem has been generally overlooked and has a number of possible causes.
- Open Access
- 1 January 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (1) , 105
Safety monitoring for disease-modifying anti-rheumatic drugs in primary and secondary care: adherence to local and national guidelines and patients' views
Sir, We were aware that our safety-monitoring requirement for disease-modifying anti-rheumatic drugs (DMARDs) had grown enormously (from 10% of RA patients in 1984 to 80% in 1994), without additional resources, and may no longer have met the patients' needs. We therefore undertook a survey to describe adherence to recommended monitoring intervals for DMARDs in primary and secondary care, to examine patients' views and experiences of DMARD information and monitoring systems and their preferences for change. A questionnaire was sent to the 1838 adult patients prescribed DMARD therapy for a variety of diagnoses from one hospital, addressing these questions.
- 1 January 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (1) , 105
Open AccessSafety monitoring for disease-modifying anti-rheumatic drugs in primary and secondary care: adherence to local and national guidelines and patients' views
Sir, We were aware that our safety-monitoring requirement for disease-modifying anti-rheumatic drugs (DMARDs) had grown enormously (from 10% of RA patients in 1984 to 80% in 1994), without additional resources, and may no longer have met the patients' needs. We therefore undertook a survey to describe adherence to recommended monitoring intervals for DMARDs in primary and secondary care, to examine patients' views and experiences of DMARD information and monitoring systems and their preferences for change. A questionnaire was sent to the 1838 adult patients prescribed DMARD therapy for a variety of diagnoses from one hospital, addressing these questions.
- Open Access
- 16 July 2003
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 42 (11) , 1423-1425
Musculoskeletal examination for children and adolescents: do standard textbooks contain enough information?
Sir, Musculoskeletal problems are common presenting symptoms in children and adolescents. They are usually of self-limiting origin but can be a presenting feature of severe, even life-threatening illness (e.g. leukaemia). Patients may present in varied guises to primary or secondary care (including paediatrics, orthopaedics, rheumatology and accident and emergency departments). Symptoms may not be volunteered and a competent musculoskeletal examination, coupled with understanding of the age-dependent variation of normal joint appearance, may be the only way to detect important joint abnormalities. It is imperative, therefore, that all clinicians caring for children and adolescents are competent in musculoskeletal assessment, to facilitate prompt diagnosis, early referral to appropriate specialist teams [1] and ultimately to optimize functional outcome.
- 16 July 2003
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 42 (11) , 1423-1425
Open AccessMusculoskeletal examination for children and adolescents: do standard textbooks contain enough information?
Sir, Musculoskeletal problems are common presenting symptoms in children and adolescents. They are usually of self-limiting origin but can be a presenting feature of severe, even life-threatening illness (e.g. leukaemia). Patients may present in varied guises to primary or secondary care (including paediatrics, orthopaedics, rheumatology and accident and emergency departments). Symptoms may not be volunteered and a competent musculoskeletal examination, coupled with understanding of the age-dependent variation of normal joint appearance, may be the only way to detect important joint abnormalities. It is imperative, therefore, that all clinicians caring for children and adolescents are competent in musculoskeletal assessment, to facilitate prompt diagnosis, early referral to appropriate specialist teams [1] and ultimately to optimize functional outcome.
- Open Access
- 27 June 2003
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 42 (12) , 1518-1522
Doctor-patient communication in a musculoskeletal unit: relationship between an observer-rated structured scoring system and patient opinion
Objectives. To investigate the ability of consultant rheumatologists and orthopaedic surgeons to communicate well with patients and to determine the validity of a structured proforma used to assess medical students’ communication skills. Methods. Seventy new patient appointments with consultant rheumatologists and orthopaedic surgeons were assessed for communication skills exhibited by the consultants and patient satisfaction. Communication skills were assessed using a proforma previously used to examine medical students, and patient ratings were obtained using visual analogue scales. Results. Median scores attained using the structured proforma for rheumatology, elective orthopaedic and fracture clinic consultations were 17, 15 and 14 out of 20 (P < 0.05). Patient satisfaction scores were high in all three domains measured. Scores were statistically significantly higher for rheumatology appointments than in fracture clinic (median scores 29.5, 29.5 and 28 out of 30). Consultation durations varied, with a median of 23 min for rheumatology and 10.5 and 4 min for orthopaedic surgeons in clinic and fracture clinic, respectively. Conclusions. Consultant rheumatologists and orthopaedic surgeons demonstrate good communication skills, according to a tool used to assess medical students. These scores correlate with patient views, suggesting that teaching and assessment of communication skills at medical schools may address concerns of patients. Scores and satisfaction correlate with the duration of the consultation.
- 27 June 2003
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 42 (12) , 1518-1522
Open AccessDoctor-patient communication in a musculoskeletal unit: relationship between an observer-rated structured scoring system and patient opinion
Objectives. To investigate the ability of consultant rheumatologists and orthopaedic surgeons to communicate well with patients and to determine the validity of a structured proforma used to assess medical students’ communication skills. Methods. Seventy new patient appointments with consultant rheumatologists and orthopaedic surgeons were assessed for communication skills exhibited by the consultants and patient satisfaction. Communication skills were assessed using a proforma previously used to examine medical students, and patient ratings were obtained using visual analogue scales. Results. Median scores attained using the structured proforma for rheumatology, elective orthopaedic and fracture clinic consultations were 17, 15 and 14 out of 20 (P < 0.05). Patient satisfaction scores were high in all three domains measured. Scores were statistically significantly higher for rheumatology appointments than in fracture clinic (median scores 29.5, 29.5 and 28 out of 30). Consultation durations varied, with a median of 23 min for rheumatology and 10.5 and 4 min for orthopaedic surgeons in clinic and fracture clinic, respectively. Conclusions. Consultant rheumatologists and orthopaedic surgeons demonstrate good communication skills, according to a tool used to assess medical students. These scores correlate with patient views, suggesting that teaching and assessment of communication skills at medical schools may address concerns of patients. Scores and satisfaction correlate with the duration of the consultation.